Abstract
Most patients reporting more than one well-documented or witnessed seizure require prophylactic antiepileptic (AED) therapy. Those with an underlying brain disorder and/or an abnormal electroencephalogram should probably be treated after their first event. The goal should be maintenance of a normal lifestyle by complete seizure control with no or minimal side-effects. Failure of the first AED due to lack of efficacy implies refractoriness. A policy of consecutive substitutions is unlikely to be an effective strategy. Thus, if the first or second monotherapy improves control but does not produce seizure freedom, an AED with different and perhaps multiple mechanisms of action should be added. Strategies for combining drugs should involve individual assessment of patient-related factors, including seizure type and epilepsy syndrome classifications coupled with an understanding of the pharmacology, side-effects and interaction profile of the AEDs. Reducing the dose of one or more AEDs may help accommodate the introduction of a second or third drug. An orderly approach to the pharmacological management and, when appropriate, surgical investigations for each epilepsy syndrome will optimise the chance of perfect seizure control and help more people achieve safer and more fulfilled lives.
Similar content being viewed by others
References
Beghi E, Gatti G, Tonini C, Ben-Menachem E, Chadwick DW, Nikanorova M, Gromov SA, Smith PEM, Spechio LM, Perucca E on behalf of BASE Study Group (2003) Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic trial. Epilepsy Res 57:1–13
Berg AT, Shinnar S (1991) The risk of seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology 41:965–72
Berg AT, Langfitt J, Shinnar S, Vickrey BG, Sperling MR, Walczaz J, Bazil C, Pascia SV, Spencer SS (2003) How long does it take for partial epilepsy to become intractable? Neurology 60:186–190
Brodie MJ, French JA (2000) Management of epilepsy in adolescents and adults. Lancet 356:323–329
Brodie MJ, Kwan P (2001) The star systems: overview and use in determining antiepileptic drug choice. CNS Drugs 15:1–12
Brodie MJ, Kwan P (2002) Staged approach to epilepsy management. Neurology 58(Suppl 5):S2–S8
Brodie MJ, Leach JP (2003) Success or failure with antiepileptic drug therapy: beyond empiricism? Neurology 60:162–1634
Brodie MJ, Yuen AW and the 105 Study Group (1997) Lamotrigine substitution study: evidence for synergism with sodium valproate? Epilepsy Res 26:423–432
Deckers CL, Hekster YA, Keyser A, Meinardi H, Renier WO (1997) Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 38:570–575
Deckers CL, Czuczwar SJ, Hekster YA, Keyser A, Kubova H, Meinardi H, Patsalos PN, Renier WO, Van Rijn CM (2000) Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 41:1364–1374
Devinsky O (1999) Patients with refractory seizures. N Engl J Med 340:1565–1570
Dlugos DJ, Sammel MD, Strom BL, Farrar JT (2001) Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 57:2259–2264
Engel J, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B (2003) Practice parameter: temporal lobe and localised neocortical resections for epilepsy: Report of the Standards Subcommittees of the American Academy of Neurology in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology 60:538–547
Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342:314–319
Kwan P, Brodie MJ (2000) Epilepsy after the first drug fails: substitution or add-on? Seizure 9:464–468
Kwan P, Brodie MJ (2001) Effectiveness of first antiepileptic drug. Epilepsia 42:1255–1260
Kwan P, Brodie MJ (2001) Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357:216–222
Kwan P, Brodie MJ (2002) Refractory epilepsy: a progressive, intractable but preventable condition? Seizure 11:77–84
Kwan P, Brodie MJ (2004) Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 45:1141–1149
Kwan P, Sills GJ, Brodie MJ (2001) The mechanisms of action of commonly used antiepileptic drugs. Pharmac Ther 90:21–34
Meldrum BS (2001) Why and when are seizures bad for the brain? Trends Pharmacol Sci 22:445–446
Mohanraj R, Brodie MJ (2003) Predicting outcomes in newly diagnosed epilepsy. Epilepsia 44(Suppl 9):15–16
Mohanraj R, Brodie MJ (2003) Measuring the efficacy of antiepileptic drugs. Seizure 12:413–443
Musicco M, Beghi E, Solari A, Viani F (1997) Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. Neurology 49:991–998
Pedley TA, Hauser WA (2002) Sudden death in epilepsy: a wake-up call for management. Lancet 359:1790–1791
Perucca E (1998) Pharmacoresistance in epilepsy: how should it be defined? CNS Drugs 10:171–179
Pisani F, Otero G, Russo MF, Di Perri R, Perucca E, Richens A (1999) The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia 40:1141–1146
Reynold EH (1990) Changing view of prognosis of epilepsy. BMJ 301:1112–1114
Rowan AJ, Meijer JWA, de Beer-Pawlikowski N, Van der Geest P, Meinardi H (1983) Valproate ethosuximide combination therapy for refractory absence seizures. Arch Neurol 40:797–802
Schachter SC (2002) Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic. Epilepsy Res 50:67–70
Sillanpää M, Jalava M, Kaleva O, Shinnar S (1998) Long-term prognosis of seizures with onset in childhood. N Engl J Med 338:1715–1722
Stephen LJ, Sills GJ, Brodie MJ (1998) Lamotrigine and topiramate may be a useful combination. Lancet 351:958–959
Stephen LJ, Brodie MJ (2002) Seizure-freedom with more than one antiepileptic drug. Seizure 11:349–351
Travethan E, Gilliam F (2003) Lost years. Delayed referral for surgically treatable epilepsy. Neurology 61:432–433
Vermeulen J, Aldenkamp AP (1995) Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research. Epilepsy Res 22:65–95
Wiebe S, Blume WT, Girvin JP, Eliasziw M for the Effectiveness and Efficacy of Surgery for Temporal Lobe Epilepsy Study Group (2001) A randomized, controlled trial of surgery for temporal lobe epilepsy. N Engl J Med 345:311–318
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brodie, M.J. Medical therapy of epilepsy: When to initiate treatment and when to combine?. J Neurol 252, 125–130 (2005). https://doi.org/10.1007/s00415-005-0735-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00415-005-0735-x